AUTOLUS THERAPEUTICS PLC (AUTL) Institutional Ownership Changes & 13F Activity
AUTOLUS THERAPEUTICS PLC (AUTL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mak Capital One Llc, Armistice Capital, Llc, Tetragon Partners Gp Ltd, Schroder Investment Management Group, and Frazier Life Sciences Management, L.P..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Garton & Associates Financial Advisors Llc | Buy | +600 | — | 600 | $1.19K | Q4 2025 | Feb 18, 2026 |
| Mak Capital One Llc | Buy | +30,005,343 | — | 30,005,343 | $59.71M | Q4 2025 | Feb 17, 2026 |
| Armistice Capital, Llc | Buy | +17,500,000 | — | 17,500,000 | $34.83M | Q4 2025 | Feb 17, 2026 |
| Tetragon Partners Gp Ltd | Buy | +9,500,000 | — | 9,500,000 | $18.91M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +1,960,766 | — | 1,960,766 | $3.90M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +1,159,791 | — | 1,159,791 | $2.31M | Q4 2025 | Feb 17, 2026 |
| Cetera Investment Advisers | Buy | +1,099,750 | — | 1,099,750 | $2.19M | Q4 2025 | Feb 17, 2026 |
| Susquehanna International Group, Llp | Buy | +598,987 | — | 598,987 | $1.19M | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +305,359 | — | 305,359 | $607.66K | Q4 2025 | Feb 17, 2026 |
| Tudor Investment Corp Et Al | Buy | +282,113 | — | 282,113 | $561.40K | Q4 2025 | Feb 17, 2026 |
| Dafna Capital Management Llc | Buy | +179,316 | — | 179,316 | $356.84K | Q4 2025 | Feb 17, 2026 |
| Xtx Topco Ltd | Buy | +129,246 | — | 129,246 | $257.20K | Q4 2025 | Feb 17, 2026 |
| Two Sigma Securities, Llc | Buy | +66,579 | — | 66,579 | $132.49K | Q4 2025 | Feb 17, 2026 |
| Scientech Research Llc | Buy | +48,572 | — | 48,572 | $96.66K | Q4 2025 | Feb 17, 2026 |
| Quadrature Capital Ltd | Buy | +42,341 | — | 42,341 | $84.26K | Q4 2025 | Feb 17, 2026 |
| Prelude Capital Management, Llc | Buy | +32,008 | — | 32,008 | $63.70K | Q4 2025 | Feb 17, 2026 |
| Delaney Dennis R | Buy | +24,000 | — | 24,000 | $47.76K | Q4 2025 | Feb 17, 2026 |
| Osaic Holdings, Inc. | Buy | +20,074 | — | 20,074 | $39.95K | Q4 2025 | Feb 17, 2026 |
| Sih Partners, Lllp | Buy | +14,887 | — | 14,887 | $29.63K | Q4 2025 | Feb 17, 2026 |
| Royal Bank Of Canada | Buy | +10,000 | — | 10,000 | $20.00K | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +8,449 | — | 8,449 | $16.81K | Q4 2025 | Feb 17, 2026 |
| Schroder Investment Management Group | Buy | +9,489,345 | — | 9,489,345 | $18.69M | Q4 2025 | Feb 13, 2026 |
| Frazier Life Sciences Management, L.P. | Buy | +4,623,324 | — | 4,623,324 | $9.20M | Q4 2025 | Feb 13, 2026 |
| Bnp Paribas Asset Management Holding S.A. | Buy | +3,361,156 | — | 3,361,156 | $6.69M | Q4 2025 | Feb 13, 2026 |
| Laurion Capital Management Lp | Buy | +3,316,626 | — | 3,316,626 | $6.60M | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +1,397,251 | — | 1,397,251 | $2.78M | Q4 2025 | Feb 13, 2026 |
| Alphabet Inc. | Buy | +698,262 | — | 698,262 | $1.39M | Q4 2025 | Feb 13, 2026 |
| Marshall Wace, Llp | Buy | +270,277 | — | 270,277 | $537.85K | Q4 2025 | Feb 13, 2026 |
| Diametric Capital, Lp | Buy | +199,922 | — | 199,922 | $397.84K | Q4 2025 | Feb 13, 2026 |
| Wells Fargo & Company/Mn | Buy | +197,083 | — | 197,083 | $392.19K | Q4 2025 | Feb 13, 2026 |
Frequently asked questions about AUTL activity
Which institutional owners are buying AUTL?
Institutional owners buying AUTL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AUTL activity?
"Buy" means an investor increased their reported position in AUTL compared to the prior reporting period. This reflects growing exposure to AUTOLUS THERAPEUTICS PLC (AUTL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AUTL increasing?
Institutional interest in AUTL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related AUTL Institutional Insights
- AUTL Overview
- AUTL 13F Institutional Holders
- AUTL Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- AUTL Insider Trading & SEC Form 4 Activity
- AUTL Articles
- Top Institutional Investor Stock Rankings